175 related articles for article (PubMed ID: 28700479)
21. Effect of HIV and malaria parasites co-infection on immune-hematological profiles among patients attending anti-retroviral treatment (ART) clinic in Infectious Disease Hospital Kano, Nigeria.
Jegede FE; Oyeyi TI; Abdulrahman SA; Mbah HA; Badru T; Agbakwuru C; Adedokun O
PLoS One; 2017; 12(3):e0174233. PubMed ID: 28346490
[TBL] [Abstract][Full Text] [Related]
22. Association of single-nucleotide polymorphisms in TLR7 (Gln11Leu) and TLR9 (1635A/G) with a higher CD4T cell count during HIV infection.
Said EA; Al-Yafei F; Zadjali F; Hasson SS; Al-Balushi MS; Al-Mahruqi S; Koh CY; Al-Naamani K; Al-Busaidi JZ; Idris MA; Balkhair A; Al-Jabri AA
Immunol Lett; 2014 Jul; 160(1):58-64. PubMed ID: 24747071
[TBL] [Abstract][Full Text] [Related]
23. Effects of CD4 Cell Counts and Viral Load Testing on Mortality Rates in Patients With HIV Infection Receiving Antiretroviral Treatment: An Observational Cohort Study in Rural Southwest China.
Shen Z; Zhu Q; Tang Z; Pan SW; Zhang H; Jiang H; Chen Y; Lan G; Xing H; Liao L; Feng Y; Ruan Y; Shao Y
Clin Infect Dis; 2016 Jul; 63(1):108-14. PubMed ID: 27001800
[TBL] [Abstract][Full Text] [Related]
24. Similar changes in plasmacytoid dendritic cell and CD4 T-cell counts during primary HIV-1 infection and treatment.
Killian MS; Fujimura SH; Hecht FM; Levy JA
AIDS; 2006 Jun; 20(9):1247-52. PubMed ID: 16816552
[TBL] [Abstract][Full Text] [Related]
25. Effect of Interleukin-28B polymorphism on Interleukin-28 expression and immunological recovery amongst HIV-1-infected individuals following antiretroviral therapy.
Srinidhi BV; Fletcher GJ; Sachidanantham J; Rupali P; Ramalingam VV; Demosthenes JP; Abraham OC; Pulimood SA; Rebekah G; Kannangai R
Indian J Med Microbiol; 2017; 35(4):580-584. PubMed ID: 29405153
[TBL] [Abstract][Full Text] [Related]
26. Low CD4 T-cell counts despite low levels of circulating HIV: insights from the comparison of HIV-1 infected patients with a discordant response to antiretroviral therapy to patients with untreated advanced HIV-2 disease.
Albuquerque AS; Foxall RB; Cortesão CS; Soares RS; Doroana M; Ribeiro A; Lucas M; Antunes F; Victorino RM; Sousa AE
Clin Immunol; 2007 Oct; 125(1):67-75. PubMed ID: 17692571
[TBL] [Abstract][Full Text] [Related]
27. Safety and immunogenicity of an adjuvanted protein therapeutic HIV-1 vaccine in subjects with HIV-1 infection: a randomised placebo-controlled study.
Harrer T; Plettenberg A; Arastéh K; Van Lunzen J; Fätkenheuer G; Jaeger H; Janssens M; Burny W; Collard A; Roman F; Loeliger A; Koutsoukos M; Bourguignon P; Lavreys L; Voss G
Vaccine; 2014 May; 32(22):2657-65. PubMed ID: 24144472
[TBL] [Abstract][Full Text] [Related]
28. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
[TBL] [Abstract][Full Text] [Related]
29. The influence of HIV infection and antiretroviral therapy on the mitochondrial membrane potential of peripheral mononuclear cells.
Sternfeld T; Schmid M; Tischleder A; Mudra S; Schlamp A; Kost BP; Gruber R; Youle M; Bogner JR; Goebel FD
Antivir Ther; 2007; 12(5):769-78. PubMed ID: 17713160
[TBL] [Abstract][Full Text] [Related]
30. Expansion of interferon-γ-secreting HIV-specific T cells during successful antiretroviral therapy.
Gasser O; Brander C; Wolbers M; Brown NV; Rauch A; Günthard HF; Battegay M; Hess C;
HIV Med; 2013 Apr; 14(4):241-6. PubMed ID: 22934786
[TBL] [Abstract][Full Text] [Related]
31. Reduction of inflammation and T cell activation after 6 months of cART initiation during acute, but not in early chronic HIV-1 infection.
de Paula HHS; Ferreira ACG; Caetano DG; Delatorre E; Teixeira SLM; Coelho LE; João EG; de Andrade MM; Cardoso SW; Grinsztejn B; Veloso VG; Morgado MG; Guimarães ML; Côrtes FH
Retrovirology; 2018 Dec; 15(1):76. PubMed ID: 30541557
[TBL] [Abstract][Full Text] [Related]
32. Influence of Injection Drug Use-Related HIV Acquisition on CD4 Response to First Antiretroviral Therapy Regimen Among Virally Suppressed Individuals.
Calkins KL; Lesko CR; Chander G; Moore RD; Lau B
J Acquir Immune Defic Syndr; 2018 Mar; 77(3):317-324. PubMed ID: 29210833
[TBL] [Abstract][Full Text] [Related]
33. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
[TBL] [Abstract][Full Text] [Related]
34. Evidence for extended age dependent maternal immunity in infected children: mother to child transmission of HIV infection and potential interventions including sulfatides of the human fetal adnexa and complementary or alternative medicines.
Bhargav H; Huilgol V; Metri K; Sundell IB; Tripathi S; Ramagouda N; Jadhav M; Raghuram N; Ramarao NH; Koka PS
J Stem Cells; 2012; 7(3):127-53. PubMed ID: 23619381
[TBL] [Abstract][Full Text] [Related]
35. Disruption of intestinal CD4+ T cell homeostasis is a key marker of systemic CD4+ T cell activation in HIV-infected individuals.
Gordon SN; Cervasi B; Odorizzi P; Silverman R; Aberra F; Ginsberg G; Estes JD; Paiardini M; Frank I; Silvestri G
J Immunol; 2010 Nov; 185(9):5169-79. PubMed ID: 20889546
[TBL] [Abstract][Full Text] [Related]
36. High CMV IgG antibody levels are associated to a lower CD4+ RESPONSE to antiretroviral therapy in HIV-infected women.
Giuliano M; Pirillo MF; Liotta G; Andreotti M; Jere H; Sagno JB; Ciccacci F; Amici R; Marazzi MC; Vella S; Palombi L; Mancinelli S
J Clin Virol; 2017 Nov; 96():17-19. PubMed ID: 28918126
[TBL] [Abstract][Full Text] [Related]
37. Naive and Memory CD4⁺ T Cells Are Differentially Affected in Indonesian HIV Patients Responding to ART.
Tanaskovic S; Fernandez S; Saraswati H; Yunihastuti E; Gani RA; Djauzi S; Price P
Viral Immunol; 2016 Apr; 29(3):176-83. PubMed ID: 27035638
[TBL] [Abstract][Full Text] [Related]
38. Timing of antiretroviral therapy initiation after diagnosis of recent human immunodeficiency virus infection and CD4(+) T-cell recovery.
Ding Y; Duan S; Wu Z; Ye R; Yang Y; Yao S; Wang J; Xiang L; Jiang Y; Lu L; Jia M; Detels R; He N
Clin Microbiol Infect; 2016 Mar; 22(3):290.e5-8. PubMed ID: 26627338
[TBL] [Abstract][Full Text] [Related]
39. Effects of Antiretroviral Therapy on Immune Function and Arterial Inflammation in Treatment-Naive Patients With Human Immunodeficiency Virus Infection.
Zanni MV; Toribio M; Robbins GK; Burdo TH; Lu MT; Ishai AE; Feldpausch MN; Martin A; Melbourne K; Triant VA; Suchindran S; Lee H; Hoffmann U; Williams KC; Tawakol A; Grinspoon SK
JAMA Cardiol; 2016 Jul; 1(4):474-80. PubMed ID: 27438325
[TBL] [Abstract][Full Text] [Related]
40. A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
; Danel C; Moh R; Gabillard D; Badje A; Le Carrou J; Ouassa T; Ouattara E; Anzian A; Ntakpé JB; Minga A; Kouame GM; Bouhoussou F; Emieme A; Kouamé A; Inwoley A; Toni TD; Ahiboh H; Kabran M; Rabe C; Sidibé B; Nzunetu G; Konan R; Gnokoro J; Gouesse P; Messou E; Dohoun L; Kamagate S; Yao A; Amon S; Kouame AB; Koua A; Kouamé E; Ndri Y; Ba-Gomis O; Daligou M; Ackoundzé S; Hawerlander D; Ani A; Dembélé F; Koné F; Guéhi C; Kanga C; Koule S; Séri J; Oyebi M; Mbakop N; Makaila O; Babatunde C; Babatounde N; Bleoué G; Tchoutedjem M; Kouadio AC; Sena G; Yededji SY; Assi R; Bakayoko A; Mahassadi A; Attia A; Oussou A; Mobio M; Bamba D; Koman M; Horo A; Deschamps N; Chenal H; Sassan-Morokro M; Konate S; Aka K; Aoussi E; Journot V; Nchot C; Karcher S; Chaix ML; Rouzioux C; Sow PS; Perronne C; Girard PM; Menan H; Bissagnene E; Kadio A; Ettiegne-Traore V; Moh-Semdé C; Kouame A; Massumbuko JM; Chêne G; Dosso M; Domoua SK; N'Dri-Yoman T; Salamon R; Eholié SP; Anglaret X
N Engl J Med; 2015 Aug; 373(9):808-22. PubMed ID: 26193126
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
